All In Biotech

Drug Trial Radar · NCT03482011

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1

Last checked: Nov 20, 2026Latest source record: Sep 25, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 530 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

530

Actual

Start

Apr 24, 2018

Primary completion

Mar 21, 2019

Study completion Jan 16, 2020

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Mar 29, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of mirikizumab in participants with moderate to severe plaque psoriasis.

Conditions

  • Psoriasis

Interventions

  • MirikizumabDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With a Static Physician's Global Assessment of (sPGA) (0,1) With at Least a 2-point Improvement From BaselineTime frame: Week 16
  2. Percentage of Participants Achieving a ≥90% Improvement From Baseline in Psoriasis Area and Severity Score (PASI 90)Time frame: Week 16

Locations

69 sites in 9 countries. Site status is shown where the registry gives one.

  • Univ of Connecticut

    Farmington, Connecticut

  • Florida Academic Dermatology Centers

    Coral Gables, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Forward Clinical Trials, Inc

    Tampa, Florida

  • Arlington Dermatology

    Rolling Meadows, Illinois

  • The South Bend Clinic

    South Bend, Indiana

  • Oregon Medical Research Center

    Portland, Oregon

  • Dermatology and Skin Surgery Center

    Exton, Pennsylvania

  • University of Utah MidValley Dematology

    Murray, Utah

  • Multicare Health System

    Tacoma, Washington

  • Charité Universitätsmedizin Berlin

    Berlin, Germany

  • ISA GmbH

    Berlin, Germany

  • Universitätsklinikum Hamburg - Eppendorf

    Hamburg, Germany

  • Clinical Research Hamburg GmbH

    Hamburg, Germany

  • Gemeinschaftspraxis Mahlow

    Mahlow, Brandenburg, Germany

  • Universitätsklinikum Münster

    Münster, North Rhine-Westphalia, Germany

  • Praxis Gerlach

    Dresden, Saxony, Germany

  • Toho University School of Medicine, Sakura Hospital

    Sakura, Chiba, Japan

  • Takagi Dermatological Clinic

    Obihiro, Hokkaido, Japan

  • Kanto Rosai Hospital

    Kawasaki, Kanagawa, Japan

  • Yokohama City University Hospital

    Yokohama, Kanagawa, Japan

  • Ryukyu University Hospital

    Nakagami-gun, Okinawa, Japan

  • Kume Clinic

    Nishi-ku Sakai-shi, Osaka, Japan

  • Shimane University Hospital

    Izumo, Shimane, Japan

  • Tokyo Medical University Hachioji Medical Center

    Hachiōji, Tokyo, Japan

  • NTT Medical Center Tokyo

    Shinagawa-KU, Tokyo, Japan

  • Tokyo Medical University Hospital

    Shinjuku-ku, Tokyo, Japan

  • Seibo Hospital

    Shinjuku-ku, Tokyo, Japan

  • Shirasaki Clinic

    Takaoka-shi, Toyama, Japan

  • RM Pharma Specialists S.A. de C.V.

    Distrito Federal, Mexico

  • Instituto de Investigaciones Aplicadas a la Neurociencia A.C

    Durango, Mexico

  • Centro Medico del Angel S.C.

    Mexicali, Estado de Baja California, Mexico

  • Instituto Dermatologico de Jalisco Dr. Jose Barba Rubio

    Zapopan, Jalisco, Mexico

  • Hospital de Jesus

    Mexico City, Mexico City, Mexico

  • Clínica Enfermedades Crónicas y Procedimientos Especiales SC

    Morella, Michoacán, Mexico

  • B&B Investigaciones Medicas, SC

    Mazatlán, Sinaloa, Mexico

  • Kohler Milstein Research, S.A. de C.V.

    Mérida, Yucatán, Mexico

  • NZOZ ZDROWIE Osteo-Medic

    Bialystok, Poland

  • "Dermed" Centrum Medyczne Sp. z o.o.

    Lodz, Poland

  • Lubelskie Centrum Diagnostyczne

    Świdnik, Poland

Showing 40 of 69 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.